FDA Investigator

Michelle Paxon

Latest inspection on record: Dallas, United States, June 2026 · records back to 2023

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 63 inspections across 63 sites are on record.
  • 33 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-03.

At a glance

Inspections

63

Sites

63

Observations

33

Career since

Aug 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
VA - North Texas Health Care System3 Jun 2026Biologics
Department of Army-William Beaumont Army Med Ctr -Dept of Pathology- Blood Bank15 May 2026Biologics
Baylor University Medical Center Transfusion Services22 Apr 2026Biologics
Parkland Health and Hospital Services System9 Apr 2026Biologics
Repromed Fertility Center1 Apr 2026BiologicsOn file

Sites inspected

VA - North Texas Health Care SystemDallas, United States1 insp.
Department of Army-William Beaumont Army Med Ctr -Dept of Pathology- Blood BankEl Paso, United States1 insp.
Baylor University Medical Center Transfusion ServicesDallas, United States1 insp.
Parkland Health and Hospital Services SystemDallas, United States1 insp.
Repromed Fertility CenterDallas, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Maira P Brading8 shared
Laurissa S Flowers5 shared
Bobbi J Miller3 shared
Ramon L Gonzalez-Prieto2 shared
Esther A Ofori2 shared
Abby L Mozeke1 shared
Erma Zaimova1 shared

Full investigator report

Get the verbatim findings behind Michelle Paxon's 33 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators